3202
L.-L. Wang et al. / Tetrahedron: Asymmetry 16 (2005) 3198–3204
25.1, 30.9, 34.5, 34.6, 36.1, 36.5, 65.5, 66.0, 70.9, 75.1,
76.7, 77.0, 77.3, 77.5, 110.0, 110.7, 119.0, 129.9, 133.6,
135.2, 152.9 ppm.
4.4. 1,2:5,6-Di-O-cyclohexylidene-3-[(4-methylphenylcar-
bamate)]-4-[(S)-1,10-binaphthyl-2,20-diyl]phosphite-D-
mannitol 3c and 1,2:5,6-di-O-cyclohexylidene-3-[(4-meth-
ylphenylcarbamate)-4-[(R)-1,10-binaphthyl-2,20-diyl]phos-
phite-D-mannitol 3d
Treatment of compound 1 and phenyl isocyanate as
described for compound 2a yielded compound 2c as a
white powder (0.51 g, 39%). 1H NMR (CDCl3):
d = 1.53–1.66 (m, 20H), 2.8 (d, 1H), 3.93 (dd, 1H),
4.05 (m, 2H), 4.13 (m, 2H) ppm, 4.47 (dd, J = 6.5 and
12.5 Hz, 1H), 5.10 (d, J = 5.5 Hz, 1H), 6.81 (s, 1H),
7.26–7.27 (m, 5H). 13C NMR (125 MHz, CDCl3):
d = 19.7, 22.7, 23.8, 24.1, 25.0, 30.8, 34.4, 34.6, 35.8,
36.5, 65.4, 66.1, 71.9, 74.1, 75.7, 76.0, 76.3, 76.5, 109.0,
110.8, 118.0, 128.9, 133.6, 134.2, 150.9 ppm.
Treatment of the in situ formed10 (S)-1,10-binaphthyl-
2,20-diyl-chlorophosphine (0.87 mmol) and compound
2b afforded ligand 3c, which was purified by flash chromato-
graphy (CH2Cl2/Et2O, 9/1, Rf = 0.85) to produce a white
powder (0.25 g, 40%). 31P NMR (202 MHz, CDCl3), d =
1
154.5 ppm. H NMR (CDCl3): d = 1.32–1.74 (m, 20H),
2.23 (s, 3H), 3.86 (m, 1H), 3.95 (m, 1H), 4.13 (m, 3H),
4.40 (d, J = 6.0 Hz, 1H), 4.78 (d, J = 12.5 Hz, 1H), 5.08
(d, J = 7.0 Hz, 1H), 6.49 (s, NH), 6.91–7.91 (m, 16H, Ar–
H) ppm. 13C NMR (125 MHz, CDCl3): d = 21.5, 23.9,
24.3, 25.6, 33.0, 35.5, 35.8, 36.6, 64.7, 65.9, 71.9, 76.6,
76.9, 77.0, 77.9, 109.0, 110.8, 117.9, 121.0, 122.1, 122.2,
123.2, 124.6, 124.7, 125.0, 125.1, 125.3, 126.3, 126.5, 127.0,
127.2, 128.3, 128.6, 129.8, 130.1, 130.5, 131.2, 131.8,
132.9, 133.1, 133.6, 134.8, 147.6, 148.3, 148.6, 151.3 ppm.
4.3. 1,2:5,6-Di-O-cyclohexylidene-3-[(3,5-dimethyl)phen-
ylcarbamate]-4-[(S)-1,10-binaphthyl-2,20-diyl]phosphite-D-
mannitol 3a and 1,2:5,6-di-O-cyclohexylidene-3-[(3,5-di-
methyl)phenylcarbamate]-4-[(R)-1,10-binaphthyl-2,20-di-
yl]phosphite-D-mannitol 3b
(S)-1,10-Binaphthyl-2,20-diyl-chlorophosphine (0.87 mmol)
was synthesized in situ10 and dissolved in toluene
(10 mL). Compound 2a (0.381 g, 0.8 mmol) was azeo-
tropically dried with toluene (3 · 10 mL) and then
dissolved in triethylamine (4 mL) to which DMAP
(0.01 g, 0.083 mmol) had been added. A solution of
phosphorochloridite was transferred slowly to a solution
of compound 2a at 0 ꢁC. The reaction mixture was
stirred overnight at room temperature, and the formed
triethylamine salts were removed by filtration. Evapora-
tion of the solvent gave a white foam, which was purified
by flash chromatography (CH2Cl2/Et2O, 9/1, Rf = 0.86)
to produce 3a as white powder (0.42 g, 66%). 31P NMR
Treatment of the in situ formed10 (R)-1,10-binaphthyl-
2,20-diyl-chlorophosphine (0.87 mmol) and compound
2b afforded ligand 3d, which was purified by flash chro-
matography (CH2Cl2/Et2O, 9/1, Rf = 0.83) to produce
a white powder (0.27 g, 43%). 31P NMR (202 MHz,
1
CDCl3), d = 157.6 ppm. H NMR (CDCl3): d = 1.33–
1.84 (m, 20H), 2.20 (s, 3H), 3.73 (s, 1H), 3.94 (m, 2H),
4.07 (m, 1H), 4.18 (d, J = 8.0 Hz, 1H), 4.32 (s, 1H),
4.91 (d, J = 7.5 Hz, 1H), 5.01 (d, J = 6.5 Hz, 1H), 6.46
(s, NH), 6.99–7.88 (m, 16H, Ar–H) ppm. 13C NMR
(125 MHz, CDCl3): d = 21.0, 24.0, 24.3, 25.5, 33.9,
35.2, 35.9, 36.7, 64.0, 66.9, 72.9, 75.6, 77.0, 77.3, 77.5,
109.9, 110.5, 118.9, 122.0, 122.1, 122.2, 123.1, 124.6,
124.7, 125.0, 125.1, 125.3, 126.2, 126.5, 127.2, 127.3,
128.5, 128.6, 129.8, 130.2, 130.5, 131.4, 131.8, 132.9,
133.1, 133.7, 134.9, 147.6, 148.5, 148.6, 150.8 ppm.
1
(202 MHz, CDCl3), d = 153.7 ppm. H NMR (CDCl3):
d = 1.61–1.86 (m, 20H), 2.30 (s, 6H), 3.94–4.14 (m,
3H), 4.29 (s, 2H), 4.53 (d, J = 7.0 Hz, 1H), 4.92 (s,
1H), 5.22 (d, J = 7.5 Hz, 1H), 6.74 (s, NH), 7.01–8.02
(m, 15H, Ar–H) ppm. 13C NMR (125 MHz, CDCl3):
d = 21.6, 21.7, 24.0, 24.3, 25.5, 33.9, 35.3, 35.9, 36.8,
64.1, 66.9, 72.9, 74.3, 75.1, 75.6, 77.1, 77.3, 77.6, 110.0,
110.6, 116.6, 122.0, 122.3, 123.2, 124.7, 125.3, 125.6,
125.9, 126.3, 126.5, 127.3, 128.5, 128.6, 129.3, 130.2,
130.6, 131.4, 131.8, 132.9, 133.1, 137.3, 138.1, 139.1,
147.3, 147.6, 148.6, 152.3 ppm.
4.5. 1,2:5,6-Di-O-cyclohexylidene-3-phenylcarbamate-4-
[(S)-1,10-binaphthyl-2,20-diyl]phosphite-D-mannitol 3e and
1,2:5,6-di-O-cyclohexylidene-3-phenylcarbamate-4-[(R)-
1,10-binaphthyl-2,20-diyl]phosphite-D-mannitol 3f
Treatment of the in situ formed10 (S)-1,10-binaphthyl-
2,20-diyl-chlorophosphine (0.87 mmol) and compound
2c afforded ligand 3e, which was purified by flash chro-
matography (CH2Cl2/Et2O, 9/1, Rf = 0.87) to produce a
white powder (0.26 g, 43%). 31P NMR (202 MHz,
Treatment of the in situ formed10 (R)-1,10-binaphthyl-
2,20-diyl-chlorophosphine (0.87 mmol) and compound
2a afforded ligand 3b, which was purified by flash chro-
matography (CH2Cl2/Et2O, 9/1, Rf = 0.87) to produce a
white powder (0.30 g, 47%). 31P NMR (202 MHz,
1
CDCl3), d = 154.5 ppm. H NMR (CDCl3): d = 1.32–
1.74 (m, 20H), 2.23 (s, 3H), 3.86 (m, 1H), 3.95 (m,
1H), 4.13 (m, 3H), 4.40 (d, J = 6.5 Hz, 1H), 4.78 (d,
J = 7.0 Hz, 1H), 5.08 (d, J = 8.0 Hz, 1H), 6.49 (s,
NH), 6.91–7.91 (m, 16H, Ar–H) ppm. 13C NMR
(125 MHz, CDCl3): d = 24.1, 24.2, 24.7, 25.3, 25.6,
33.9, 35.2, 35.6, 36.7, 64.0, 66.3, 72.7, 75.0, 77.0, 77.3,
77.5, 109.0, 110.6, 113.3, 118.0, 118.4, 122.1, 122.8,
123.7, 124.0, 124.5, 124.6, 124.9, 125.6, 126.6, 127.0,
127.1, 127.7, 128.0, 128.9, 129.0, 129.3, 129.5, 130.0,
130.6, 131.6, 132.8, 133.1, 133.8, 152.6 ppm.
1
CDCl3), d = 156.6 ppm. H NMR (CDCl3): d = 1.32–
1.71 (m, 20H), 2.31 (s, 6H), 3.87 (s, 1H), 4.08 (d,
J = 22 Hz, 2H), 4.23 (s, 1H), 4.34 (d, J = 4.5 Hz, 1H),
4.46 (s, 1H), 5.06 (d, J = 7.0 Hz, 1H), 5.15 (d,
J = 6.5 Hz, 1H), 6.56 (s, NH), 6.75–8.01 (m, 15H, Ar–
H) ppm. 13C NMR (125 MHz, CDCl3): d = 21.0, 21.7,
24.0, 24.3, 26.5, 33.9, 35.3, 36.8, 64.1, 66.9, 73.9, 74.3,
75.1, 75.3, 75.9, 77.1, 77.3, 77.6, 110.0, 110.6, 116.6,
122.0, 122.8, 123.2, 124.7, 125.1, 125.3, 125.6, 125.9,
126.4, 126.5, 127.3, 128.5, 128.6, 129.3, 130.2, 130.6,
131.1, 131.8, 132.9, 133.1, 137.3, 138.1, 139.1, 147.2,
147.6, 148.9 ppm.
Treatment of the in situ formed10 (R)-1,10-binaphthyl-
2,20-diyl-chlorophosphine (0.87 mmol) and compound